On March 27, 2023,BioNxt Solutions Inc. closed the transaction. The company has issued 4,050,000 units at CAD 0.50 per Unit for total gross proceeds of CAD 2,025,000. The Company paid CAD 159,600 and issued 319,200 share purchase warrants in finder's fees with respect to the placement.

Each finder's warrant is exercisable into one common share at a price of CAD 0.75 per share for a period of 24 months from date of issue.